Time-to-onset in spontaneous reports: The possibility to detect the unexpected

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 5, 2013, Pages 556-557

  Karimi, Ghazaleh ^a   Star, Kristina ^a   Hägg, Staffan ^b   Norén, G Niklas ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; COWORKER; DRUG SURVEILLANCE PROGRAM; HEALTH PRACTITIONER; HUMAN; IMMUNIZATION; LETTER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; INFLUENZA VACCINES; MODELS, STATISTICAL; ROTAVIRUS VACCINES;

EID: 84877324718     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3397     Document Type: Letter

References (5)

1. Van Holle L, Zeinoun Z, Bauchau V, Verstraeten T. Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study. Pharmacoepidemiol Drug Saf 2012; 21(6): 603-10.
2. Wood SM, Mann RD, Rawlins MD. Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. BMJ (Clin Res Ed) 1987; 294(6564): 91-2. Epub 1987/01/10.
3. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988; 260(7): 967-70. Epub 1988/08/19.
4. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andren L, Wiholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1992; 304(6832): 941-6. Epub 1992/04/11.
5. Khodabakhshi G, Star K, Norén GN, Hägg S. Variations across drug classes in reported time-to-onset of suspected adverse drug reactions. Drug Saf 2010; 33(10): 926.